Virulence factors in Escherichia coli [8]

Journal of Clinical Microbiology

Volumn 43, Issue 12, 2005, Pages 6221-

  Johnson, James R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; HEMOLYSIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; ESCHERICHIA COLI; LETTER; MULTIDRUG RESISTANCE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIURIA; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; NALIDIXIC ACID; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 30744445467     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.12.6221-6222.2005     Document Type: Letter

References (8)

1. Drews, S. J., S. M. Poutanen, T. Mazulli, A. J. McGeer, A. Sarabia, S. Pong-Porter, Y. Rzayev, B. Willey, K. Green, and D. E. Low. 2005. Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J. Clin. Microbiol. 43:4218-4220.
2. Johnson, J. R., B. Johnston, R. Raz, R. Colodner, and M. Kuskowski. 2005. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob. Agents Chemother. 49:4739-4744.
3. Johnson, J. R., M. A. Kuskowski, A. Gajewski, D. F. Sahm, and J. A. Karlowsky. 2004. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J. Infect. Dis. 190:1739-1744.
4. Johnson, J. R., M. A. Kuskowski, T. T. O'Bryan, R. Colodner, and R. Raz. 2005. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob. Agents Chemother. 46:26-31.
5. Johnson, J. R., M. A. Kuskowski, K. Owens, A. Gajewski, and P. L. Winokur. 2003. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J. Infect. Dis. 188:759-768.
6. Johnson, J. R., C. Van der Schee, M. A. Kuskowski, W. Goessens, and A. Van Belkum. 2002. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from The Netherlands. J. Infect. Dis. 186:1852-1856.
7. Kuntaman, K., E. S. Lestari, J. A. Severin, I. M. Kershof, N. M. Mertaniasih, M. Purwanta, U. Hadi, J. R. Johnson, A. van Belkum, and H. A. Verbrugh. 2005. Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg. Infect. Dis. 11:1363-1369.
8. Martinez-Martinez, L., F. Fernandez, and E. J. Perea. 1999. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 43:277-279.